Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets
- PMID: 34382415
- PMCID: PMC8656345
- DOI: 10.4155/fmc-2021-0207
Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets
Keywords: antibiotic drug discovery; bacterial carbonic anhydrase; carbonic anhydrase inhibitors.
Conflict of interest statement
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
References
-
- Supuran CT. Structure and function of carbonic anhydrases. Biochem. J. 473(14), 2023–2032 (2016). - PubMed
-
- Clapp JW, Roblin JRO. US2554816A (1951).
-
- Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov. 7(2), 168–181 (2008). - PubMed
-
- Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin. Sci. 135(10), 1233–1249 (2021). - PubMed
-
- Capasso C, Supuran CT. Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Expert Opin. Ther. Targets 19(12), 1689–1704 (2015). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical